Prometrium Cost in South Dakota (2026): Cash Price, Medicaid, Insurance & Savings

How Much Does Prometrium Cost in South Dakota in 2026?
At a glance
- Manufacturer list price (AbbVie) / $180 per month
- Average SD cash-pay price (2026) / $45 per month
- Compounded micronized progesterone (503A) / approximately $25 per month
- South Dakota Medicaid coverage / not covered for HRT endometrial protection
- Telehealth prescribing in SD / yes, fully legal
- Standard dosing / 200 mg oral capsule, once daily at bedtime
- Prescription status / prescription only
- FDA-approved indication / prevention of endometrial hyperplasia in postmenopausal women on estrogen
- Generic availability / yes, multiple generic micronized progesterone products
- Savings programs / AbbVie savings card and pharmacy discount cards available
South Dakota Cash-Pay Pricing: $45 per Month on Average
The average cash-pay price for a 30-day supply of Prometrium 200 mg in South Dakota sits at roughly $45 in 2026. That figure reflects generic micronized progesterone dispensed at retail chains and independent pharmacies across the state.
AbbVie lists the brand-name product at $180 per month, but very few patients pay that number. Generic substitution drives most transactions to the $40 to $55 range depending on pharmacy location. Sioux Falls and Rapid City pharmacies tend to cluster near the state average. Rural pharmacies may price slightly higher because of lower dispensing volume, though the difference rarely exceeds $10 to $15.
Pharmacy discount programs from GoodRx, RxSaver, and SingleCare can push the price below $30 at select locations. These programs work at most major chains operating in South Dakota, including Walgreens, CVS (where available), Hy-Vee, and Lewis Drug. A coupon is not insurance. It simply negotiates a lower rate through a pharmacy benefit manager contract.
The PEPI trial (Postmenopausal Estrogen/Progestin Interventions, N=875) established that micronized progesterone at 200 mg per day effectively prevents endometrial hyperplasia in women taking conjugated equine estrogens, with a more favorable lipid profile than medroxyprogesterone acetate 1. That trial shaped prescribing patterns and remains the clinical backbone supporting Prometrium's role in combined hormone therapy regimens.
Patients filling prescriptions without insurance should ask their pharmacist to run multiple discount cards at the point of sale. Pharmacists in South Dakota can process these cards without a prior authorization step, and the lowest available price is applied automatically at most chains.
South Dakota Medicaid Does Not Cover Prometrium for HRT
South Dakota Medicaid does not include Prometrium on its preferred drug list for endometrial protection during hormone replacement therapy. This applies to both the brand and generic formulations when prescribed specifically for HRT-related indications.
The state's Medicaid formulary operates under a closed model for many hormone therapy products. Micronized progesterone prescribed for other FDA-approved indications (such as secondary amenorrhea) may follow different coverage pathways, but the standard HRT use case faces a coverage gap. Patients enrolled in South Dakota Medicaid who need progesterone for endometrial protection typically pay out-of-pocket or seek compounded alternatives.
Prior authorization requests can be submitted through the state's pharmacy benefit administrator, but approval rates for off-formulary HRT agents remain low based on published formulary restriction data. The South Dakota Department of Social Services publishes its preferred drug list annually, and micronized progesterone for HRT has not appeared on recent editions.
The FDA-approved prescribing information for Prometrium specifies two indications: prevention of endometrial hyperplasia in postmenopausal women receiving conjugated estrogens, and treatment of secondary amenorrhea. Coverage decisions at the state Medicaid level do not always align with FDA labeling, and South Dakota's exclusion of Prometrium for HRT is one example of that disconnect.
For Medicaid enrollees, compounded micronized progesterone through a licensed 503A pharmacy (discussed below) may offer a viable and affordable workaround at roughly $25 per month.
Insurance Coverage Across South Dakota Plans
Private insurance plans in South Dakota vary widely in how they cover Prometrium and its generic equivalents. Most commercial plans offered through the state's health insurance marketplace do cover generic micronized progesterone, typically on a Tier 2 or Tier 3 formulary position.
Avera Health Plans and Sanford Health Plan, two of the largest regional carriers, generally include generic micronized progesterone with a standard copay ranging from $10 to $35 per month. Brand-name Prometrium, if specifically requested, often requires a Tier 3 or non-preferred brand copay that can reach $60 to $80 per fill.
Employer-sponsored plans through large national carriers (UnitedHealthcare, Blue Cross Blue Shield of South Dakota, Cigna) follow their national formulary structures. Generic micronized progesterone appears on most of these formularies without prior authorization. The Endocrine Society's 2022 clinical practice guideline on hormone therapy in menopause recommends micronized progesterone as the preferred progestogen for endometrial protection based on its cardiovascular and breast safety profile 2, and many insurers reference this guideline when making formulary placement decisions.
Patients should verify coverage by calling the member services number on their insurance card before filling a prescription. Formulary placement can shift during annual plan renewals, and a drug covered in January may move tiers by July if the plan updates its formulary mid-year.
Compounded Micronized Progesterone in South Dakota: Legal and Available
Compounded micronized progesterone is legal in South Dakota through licensed 503A compounding pharmacies. These pharmacies operate under federal and state oversight and prepare patient-specific prescriptions using USP-grade micronized progesterone powder.
The average cost is approximately $25 per month for a 30-day supply. That price applies to oral capsules compounded to match the standard 200 mg bedtime dose. Some 503A pharmacies also compound progesterone into vaginal capsules, topical creams, or troches at comparable price points.
South Dakota does not impose additional state-level restrictions beyond federal 503A requirements. A compounding pharmacy must hold a valid South Dakota Board of Pharmacy license, compound pursuant to a valid patient-specific prescription, and comply with USP <795> and USP <797> standards for non-sterile and sterile compounding, respectively.
One clinical consideration: compounded products do not undergo the same bioequivalence testing as FDA-approved generics. The PEPI trial data 1 supporting endometrial protection used the branded Prometrium formulation. While the active ingredient is identical, absorption characteristics of compounded capsules can vary depending on the excipient blend and capsule fill method. The American College of Obstetricians and Gynecologists (ACOG) has noted that FDA-approved formulations are preferred when available, though compounded alternatives remain appropriate when cost or access barriers exist 3.
Patients considering compounded progesterone should confirm that their pharmacy holds current 503A licensure and ask about third-party potency testing results. Reputable compounders make these reports available on request.
Telehealth Prescribing: Fully Legal Statewide
South Dakota permits telehealth prescribing of Prometrium and generic micronized progesterone with no geographic restrictions within the state. A provider licensed in South Dakota can conduct a synchronous video or audio visit, evaluate the patient, and transmit a prescription to any South Dakota pharmacy.
The state updated its telehealth parity laws following the pandemic-era regulatory changes, and prescribing of non-controlled substances like micronized progesterone faces no additional telehealth-specific barriers. Prometrium is not a controlled substance and does not require an in-person exam prior to initial prescribing under South Dakota law.
Several national telehealth platforms serve South Dakota patients for hormone therapy consultations. Pricing for telehealth visits typically ranges from $50 to $150 for an initial consultation, with follow-up visits often discounted. Some platforms bundle the consultation fee with the prescription cost, offering micronized progesterone at $30 to $45 per month inclusive of the provider fee on a subscription model.
For patients in rural parts of the state, where the nearest endocrinologist or menopause specialist may be two or more hours away, telehealth represents a practical access pathway. The North American Menopause Society (NAMS) position statement on hormone therapy supports the use of telemedicine for initiating and managing HRT when in-person visits are impractical 4.
Prescriptions generated via telehealth are transmitted electronically to the patient's pharmacy of choice. South Dakota pharmacies accept e-prescriptions from any provider with a valid South Dakota medical license or a license from a state that participates in an interstate medical licensure compact.
AbbVie Savings Card and Other Discount Programs
AbbVie (which acquired the Prometrium brand through its Allergan portfolio) offers a manufacturer savings card for brand-name Prometrium. The card is available to commercially insured patients and can reduce out-of-pocket costs to as low as $25 per fill, depending on the terms of the current program cycle.
Key details of the savings program:
The card does not work for patients covered by Medicare, Medicaid, Tricare, or other government-funded insurance. South Dakota Medicaid enrollees are excluded. Commercially insured patients and cash-pay patients are eligible. The card applies only to the brand-name product, not to generic micronized progesterone.
Given that generic micronized progesterone already costs roughly $45 cash-pay in South Dakota, the savings card's value is most relevant for patients whose insurance specifically requires the brand product or whose generic copay exceeds the savings card floor.
Beyond the manufacturer card, several pharmacy-level discount programs operate in South Dakota:
Hy-Vee's $4 generic program includes some hormone therapy products, though micronized progesterone availability under this program varies by location. Lewis Drug, a South Dakota-based chain, offers competitive generic pricing and occasionally runs prescription discount events. Walmart's discount generic list, available at South Dakota locations, sometimes includes micronized progesterone at reduced pricing tiers.
Patients should compare the savings card price against their generic copay and any available discount card price before deciding which route to use. In many cases, generic micronized progesterone with a discount card produces the lowest total out-of-pocket cost.
How Prometrium Pricing Compares to Other Progestogens
Micronized progesterone is not the only progestogen option for endometrial protection, and cost comparisons matter for South Dakota patients managing HRT expenses.
Medroxyprogesterone acetate (Provera) is the oldest synthetic alternative. Generic medroxyprogesterone costs approximately $4 to $15 per month at South Dakota pharmacies, making it the cheapest option by a wide margin. The tradeoff is clinical: the Women's Health Initiative (WHI) trial (N=16,608) showed that the combination of conjugated equine estrogens plus medroxyprogesterone acetate was associated with increased breast cancer risk (HR 1.26 to 95% CI 1.00 to 1.59) after a mean 5.6 years of follow-up 5. Micronized progesterone has not demonstrated the same signal. The E3N cohort study (N=80,377) found no significant increase in breast cancer risk with estrogen plus micronized progesterone over a mean follow-up of 8.1 years 6.
The levonorgestrel intrauterine system (Mirena) provides endometrial protection through local progestogen delivery. Its upfront cost is higher ($800 to $1,200 for the device plus insertion), but amortized over 5 years it works out to roughly $13 to $20 per month. Insurance typically covers Mirena with a specialist copay. For patients on long-term estrogen therapy, this option deserves discussion with their prescriber.
Norethindrone acetate, another oral synthetic progestogen, runs $10 to $25 per month in generic form. It carries a different side effect profile than micronized progesterone and is less commonly prescribed for HRT endometrial protection.
"Micronized progesterone remains our first-line recommendation for endometrial protection in postmenopausal hormone therapy due to its favorable cardiovascular and breast safety data," according to the Endocrine Society's clinical practice guideline on menopausal hormone therapy 2.
Tips for Reducing Your Prometrium Cost in South Dakota
Practical steps to minimize out-of-pocket spending on micronized progesterone in South Dakota:
Request generic substitution. Every South Dakota pharmacy can substitute generic micronized progesterone for brand Prometrium unless the prescriber writes "dispense as written." Generic substitution alone drops the price from $180 to approximately $45.
Run multiple discount cards. GoodRx, RxSaver, SingleCare, and Amazon Pharmacy all offer pricing lookups by ZIP code. Prices at the same pharmacy can differ by $10 to $20 depending on which card is used.
Consider a 90-day fill. Many South Dakota pharmacies and mail-order services offer 90-day supplies at a per-unit discount. A 90-day fill of generic micronized progesterone may cost $100 to $120 total versus $135 for three separate 30-day fills.
Ask about compounding. If the $45 cash-pay price still strains your budget, a licensed 503A compounding pharmacy can prepare micronized progesterone capsules for roughly $25 per month. Confirm the pharmacy's licensure status through the South Dakota Board of Pharmacy.
Check your plan's mail-order option. Commercially insured patients often save 20% to 30% by using their plan's preferred mail-order pharmacy. Express Scripts, CVS Caremark, and OptumRx all fulfill micronized progesterone prescriptions by mail to South Dakota addresses.
The NAMS 2022 position statement recommends that clinicians consider cost as a factor in HRT regimen selection, noting that financial barriers reduce adherence and that "the most effective hormone therapy is the one the patient can afford and will take consistently" 4.
Patients taking Prometrium 200 mg at bedtime for endometrial protection should take the capsule with food to improve absorption, as the FDA label notes a significant increase in bioavailability when taken in the fed state versus fasting 7.
Frequently asked questions
›How much does Prometrium cost in South Dakota?
›Does South Dakota Medicaid cover Prometrium?
›Is compounded micronized progesterone legal in South Dakota?
›Can I get Prometrium via telehealth in South Dakota?
›Which insurance plans cover Prometrium in South Dakota?
›What's the cheapest way to get Prometrium in South Dakota?
›Are there South Dakota Prometrium discount programs?
›How does the AbbVie savings card work in South Dakota?
›Is generic micronized progesterone the same as Prometrium?
›Do I need a prescription for Prometrium in South Dakota?
References
- Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women: The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. JAMA. 1995;273(3):199-208
- Stuenkel CA, Davis SR, Gompel A, et al. Treatment of symptoms of the menopause: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2015;100(11):3975-4011
- American College of Obstetricians and Gynecologists. Compounded bioidentical menopausal hormone therapy. ACOG Committee Opinion
- The 2022 hormone therapy position statement of The North American Menopause Society. Menopause. 2022;29(7):767-794
- Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA. 2002;288(3):321-333
- Fournier A, Berrino F, Clavel-Chapelon F. Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study. Breast Cancer Res Treat. 2008;107(1):103-111
- Prometrium (progesterone) capsules prescribing information. U.S. Food and Drug Administration